Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis

Hypersensitivity to a contact allergen is one of the most abundant forms of inflammatory skin disease. Today, more than 20% of the general population are sensitized to one or more contact allergens, making this disease an important healthcare issue, as re-exposure to the allergen can initiate the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Goksøyr, Louise, Funch, Anders B., Okholm, Anna K., Theander, Thor G., de Jongh, Willem Adriaan, Bonefeld, Charlotte M., Sander, Adam F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143278/
https://www.ncbi.nlm.nih.gov/pubmed/35632584
http://dx.doi.org/10.3390/vaccines10050828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143278/
https://www.ncbi.nlm.nih.gov/pubmed/35632584
http://dx.doi.org/10.3390/vaccines10050828

Ejemplares similares